|
|
|
| The pathogenesis of depression and the research progress of antidepressants |
| GAO Guiyuan1 HUANG Jie1 LIU Dan1 ZHANG Fang1 ZHANG Chaoqun1 ZHANG Guoli1 CHEN Lihua1 SHAO Yingxin2 |
1.Department of Medicine, Huanggang Hospital of Traditional Chinese Medicine, Hubei Province, Huanggang 438000, China;
2.Department of Endocrinology, Huanggang Hospital of Traditional Chinese Medicine, Hubei Province, Huanggang 438000, China |
|
|
|
Abstract Depression, a kind of affective disorder caused by many factors. As the pace of life continues to accelerate, the competitive pressures faced by people in life and work are increasing, and the incidence of depression is increasing year by year. Therefore, the in-depth study of the pathogenesis of depression and the development of new drugs against depression are becoming more and more important. This article will review the pathogenesis of depression and the study of antidepressants for various pathogenesis.
|
|
|
|
|
|
[1] Maes M，Vandoolaeghe E，Ranjan R，et al. Increased serum interleukin-1-receptor-antagonist concentrations in major depression [J]. J Affect Disorders，1995，36（1/2）：29-36.
[2] Catena-Dell’osso M，Bellantuono C，Consoli G，et al. Inflammatory and neurodegenerative pathways in depression：a new avenue for antidepressant development？[J]. Curr Med Chem，2011，18（2）：245-255.
[3] Kim JW，Szigethy EM，Melhem NM，et al. Inflammatory markers and the pathogenesis of pediatric depression and suicide：a systematic review of the literature [J]. J Clin Psychiatry，2014，75（11）：1242-1253.
[4] Juengst SB，Kumar RG，Failla MD，et al. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury [J]. J Head Trauma Rehabil，2015，30（3）：207-218.
[5] Tsao CW，Lin YS，Chen CC，et al. Cytokines and serotonin transporter in patients with major depression [J]. Prog Neuro-Psychoph，2006，30（5）：899-905.
[6] Koo JW，Russo SJ，Ferguson D，et al. Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior [J]. P Natl A Sci India A，2010，107（6）：2669-2674.
[7] Han Y，Khodr CE，Sapru MK，et al. A microRNA embedd-ed AAV alpha-synuclein gene silencing vector for dopam- inergic neurons [J]. Brain Res，2011，1386（8）：15-24.
[8] Zaaijer ER，Van Dijk L，De Bruin K，et al. Effect of extended-release naltrexone on striatal dopamine transporter availability，depression and anhedonia in heroin-dependent patients [J]. Psychopharmacology，2015，232（14）：2597-2607.
[9] Morrissette DA，Stahl SM. Modulating the serotonin system in the treatment of major depressive disorder [J]. CNS Spectrums，2014，19（S1）：54-68.
[10] Samuels BA，Mendez-David I，Faye C，et al. Serotonin 1A and serotonin 4 receptors：essential mediators of the neurogenic and behavioral actions of antidepressants[J]. T Neuroscientist，2016，22（1）：26-45.
[11] Neumeister A. Tryptophan depletion，serotonin，and depression：where do we stand？[J] Psychopharmacology Bulletin，2002，37（4）：99-115.
[12] Dhir A，Sarvaiya J. The efficacy of vortioxetine for the treatment of major depressive disorder [J]. Expert Rev Neurother，2014，14（12）：1349-1363.
[13] Binder EB，Salyakina D，Lichtner P，et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment [J]. Na Genet，2004，36（12）：1319-1325.
[14] Duman RS，Monteggia LM. A neurotrophic model for stress-related mood disorders [J]. Biol Psychiat，2006，59（12）：1116-1127.
[15] Taliaz D，Stall N，Dar D，et al. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis [J]. Mol Psychiat，2010，15（1）：80-92.
[16] Lee BH，Kim H，Park SH，et al. Decreased plasma BDNF level in depressive patients [J]. J Affect Disorders，2007， 101（1）：239-244.
[17] Huang TL，Lee CT，Liu YL. Serum brain-derived neurotrophic factor levels in patients with major depression：effects of antidepressants [J]. J Psychiatric Res，2008，42（7）：521-525.
[18] Chen B，Dowlatshahi D，Macqueen GM，et al. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication [J]. Biol Psychiat，2001，50（4）：260-265.
[19] Nomoto H，Baba H，Satomura E，et al. Serum brain-derived neurotrophic factor levels and personality traits in patients with major depression [J]. BMC Psychiat，2015，15（1）：33.
[20] Panja D，Bramham CR. BDNF mechanisms in late LTP formation：a synthesis and breakdown [J]. Neuropharmacology，2014，76：664-676.
[21] Naumenko V，Kondaurova E，Bazovkina D，et al. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains [J]. Neur，2012，214（12）：59-67.
[22] Wu ML，Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose [J]. Chang Gung Med J，2011，34（6）：644-649.
[23] Merzoug S，Toumi ML，Tahraoui A. Quercetin mitigates Adriamycin-induced anxiety-and depression-like behaviors，immune dysfunction，and brain oxidative stress in rats [J]. N-S Arch Pharmacol，2014，387（10）：921-933.
[24] Jangra A，Lukhi MM，Sulakhiya K，et al. Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice [J]. Eur J Pharmacol，2014，740：337-345.
[25] Zeng Z，Li Q，Piao X，et al. Forsythia suspensa extract attenuates corticosterone-induced growth inhibition，oxidative injury，and immune depression in broilers [J]. Poultry Sci，2014，93（7）：1774-1781.
[26] 戈宏焱，陈博，许丹，等.柴胡皂苷A对抑郁模型大鼠脑中单胺类神经递质及其代谢产物含量的影响[J].高等学校化学学报，2008，29（8）：1535-1538.
[27] 高世勇，倪小虎，于蕾，等.人参茎叶皂甙、人参根皂甙抗抑郁作用研究[J].哈尔滨商业大学学报：自然科学版，2002，18（2）：135-136，155. |
|
|
|
